JPS50106969A - - Google Patents

Info

Publication number
JPS50106969A
JPS50106969A JP50010179A JP1017975A JPS50106969A JP S50106969 A JPS50106969 A JP S50106969A JP 50010179 A JP50010179 A JP 50010179A JP 1017975 A JP1017975 A JP 1017975A JP S50106969 A JPS50106969 A JP S50106969A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50010179A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS50106969A publication Critical patent/JPS50106969A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50010179A 1974-01-25 1975-01-25 Pending JPS50106969A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH104774 1974-01-25

Publications (1)

Publication Number Publication Date
JPS50106969A true JPS50106969A (enExample) 1975-08-22

Family

ID=4201215

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50010179A Pending JPS50106969A (enExample) 1974-01-25 1975-01-25

Country Status (14)

Country Link
JP (1) JPS50106969A (enExample)
AT (1) ATA53175A (enExample)
AU (1) AU7756375A (enExample)
BE (1) BE824742A (enExample)
DE (1) DE2501468A1 (enExample)
DK (1) DK3375A (enExample)
ES (1) ES434079A1 (enExample)
FR (1) FR2258853B1 (enExample)
GB (1) GB1472342A (enExample)
IE (1) IE40368B1 (enExample)
IL (1) IL46505A0 (enExample)
NL (1) NL7500535A (enExample)
SE (1) SE7500262L (enExample)
ZA (1) ZA75522B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999186A (en) * 1986-06-27 1991-03-12 The Procter & Gamble Company Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
EE200200607A (et) * 2000-04-28 2004-04-15 Baxter Healthcare Sa 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
DE10152306A1 (de) * 2001-10-26 2003-07-24 Asta Medica Ag 2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
JP2010540641A (ja) * 2007-10-05 2010-12-24 アミラ ファーマシューティカルス,インコーポレーテッド 5−リポキシゲナーゼ活性化タンパク質(flap)阻害剤
BRPI1015135B1 (pt) 2009-06-29 2021-08-03 Incyte Holdings Corporation Pirimidinonas inibidoras de pi3k, composição compreendendo tais compostos, bem como usos dos mesmos
US8759359B2 (en) 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
WO2011075630A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
CA2796311A1 (en) 2010-04-14 2011-10-20 Incyte Corporation Fused derivatives as pi3k.delta. inhibitors
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
CA2822070C (en) 2010-12-20 2019-09-17 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
DK3513793T3 (da) 2011-09-02 2021-04-26 Incyte Holdings Corp Heterocyclylaminer som pi3k-inhibitorer
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
MX373232B (es) 2015-02-27 2020-05-08 Incyte Holdings Corp Sales del inhibidor fosfoinositida 3-cinasa (pi3k) y procesos para su preparación.
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
MA52761A (fr) 2018-06-01 2021-04-14 Incyte Corp Schéma posologique destiné au traitement de troubles liés à la pi3k

Also Published As

Publication number Publication date
IL46505A0 (en) 1975-04-25
ZA75522B (en) 1976-01-28
AU7756375A (en) 1976-07-29
BE824742A (fr) 1975-07-24
FR2258853A1 (enExample) 1975-08-22
GB1472342A (en) 1977-05-04
IE40368B1 (en) 1979-05-09
SE7500262L (enExample) 1975-07-28
ATA53175A (de) 1977-08-15
ES434079A1 (es) 1977-03-01
FR2258853B1 (enExample) 1978-06-30
IE40368L (en) 1975-07-25
DK3375A (enExample) 1975-09-15
DE2501468A1 (de) 1975-07-31
NL7500535A (nl) 1975-07-29

Similar Documents

Publication Publication Date Title
FR2258853B1 (enExample)
DK675A (enExample)
DK50875A (enExample)
FR2263165A1 (enExample)
FI751764A7 (enExample)
FR2266137B1 (enExample)
CS167163B1 (enExample)
CS177177B2 (enExample)
DK29074A (enExample)
CH577927A5 (enExample)
BG21049A1 (enExample)
CH576650A5 (enExample)
CH576186A5 (enExample)
CH575552A5 (enExample)
CH592563A5 (enExample)
CH578174A5 (enExample)
CH581862A5 (enExample)
CH583326B5 (enExample)
DD116411A1 (enExample)
DD112635A1 (enExample)
CH583574A5 (enExample)
BG21778A1 (enExample)
CH596566A5 (enExample)
CH568539A5 (enExample)
BG21710A1 (enExample)